Sources

4 Total Sources

Targeted Drugs Lift 5-Year Cancer Survival to 70% as 18 Million Americans Live After Diagnosis

Targeted Drugs Drive Rising Cancer Survival Rates to 70%

Scientific American12h ago

Landmark pancreatic cancer treatment paves way for targeting other tricky tumors | Scientific American

currentaffairsai.com17h ago

A new pill can double survival time for deadliest cancer: An expert explains why this is a gamechanger | CurrentAffairsAI

Instagram17h ago

A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday. The drug is called daraxonrasib and it blocks